A

Armata Pharmaceuticals Inc
AMEX:ARMP

Watchlist Manager
Armata Pharmaceuticals Inc
AMEX:ARMP
Watchlist
Price: 1.8529 USD -4.98%
Market Cap: 67m USD
Have any thoughts about
Armata Pharmaceuticals Inc?
Write Note

Intrinsic Value

ARMP's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ARMP stock under the Base Case scenario is 2.1836 USD. Compared to the current market price of 1.8529 USD, Armata Pharmaceuticals Inc is Undervalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARMP Intrinsic Value
2.1836 USD
Undervaluation 15%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
Armata Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for ARMP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ARMP?
Bearish
Neutral
Bullish

Fundamental Analysis

1.8529 USD
-4.98%
-4.98%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Armata Pharmaceuticals Inc
US
Biotechnology
Market Cap
67m USD
IPO
May 20, 1994
Employees
72
United States of America
Market Cap
67m USD
Industry
Biotechnology
IPO
May 20, 1994
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Armata Pharmaceuticals Inc

Provide an overview of the primary business activities
of Armata Pharmaceuticals Inc.

What unique competitive advantages
does Armata Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Armata Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Armata Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Armata Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Armata Pharmaceuticals Inc.

Provide P/S
for Armata Pharmaceuticals Inc.

Provide P/E
for Armata Pharmaceuticals Inc.

Provide P/OCF
for Armata Pharmaceuticals Inc.

Provide P/FCFE
for Armata Pharmaceuticals Inc.

Provide P/B
for Armata Pharmaceuticals Inc.

Provide EV/S
for Armata Pharmaceuticals Inc.

Provide EV/GP
for Armata Pharmaceuticals Inc.

Provide EV/EBITDA
for Armata Pharmaceuticals Inc.

Provide EV/EBIT
for Armata Pharmaceuticals Inc.

Provide EV/OCF
for Armata Pharmaceuticals Inc.

Provide EV/FCFF
for Armata Pharmaceuticals Inc.

Provide EV/IC
for Armata Pharmaceuticals Inc.

Show me price targets
for Armata Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Armata Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Armata Pharmaceuticals Inc?

What are the Net Income projections
for Armata Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Armata Pharmaceuticals Inc?

What are the EPS projections
for Armata Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Armata Pharmaceuticals Inc?

What are the EBIT projections
for Armata Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Armata Pharmaceuticals Inc?

Compare the revenue forecasts
for Armata Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Armata Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Armata Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Armata Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Armata Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Armata Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Armata Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Armata Pharmaceuticals Inc.

Provide ROE
for Armata Pharmaceuticals Inc.

Provide ROA
for Armata Pharmaceuticals Inc.

Provide ROIC
for Armata Pharmaceuticals Inc.

Provide ROCE
for Armata Pharmaceuticals Inc.

Provide Gross Margin
for Armata Pharmaceuticals Inc.

Provide Operating Margin
for Armata Pharmaceuticals Inc.

Provide Net Margin
for Armata Pharmaceuticals Inc.

Provide FCF Margin
for Armata Pharmaceuticals Inc.

Show all solvency ratios
for Armata Pharmaceuticals Inc.

Provide D/E Ratio
for Armata Pharmaceuticals Inc.

Provide D/A Ratio
for Armata Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Armata Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Armata Pharmaceuticals Inc.

Provide Quick Ratio
for Armata Pharmaceuticals Inc.

Provide Current Ratio
for Armata Pharmaceuticals Inc.

Provide Cash Ratio
for Armata Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Armata Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Armata Pharmaceuticals Inc?

What is the current Free Cash Flow
of Armata Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Armata Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Armata Pharmaceuticals Inc

Current Assets 22.4m
Cash & Short-Term Investments 17.1m
Receivables 2.2m
Other Current Assets 3m
Non-Current Assets 75.8m
PP&E 55.9m
Intangibles 13.7m
Other Non-Current Assets 6.2m
Current Liabilities 118.2m
Accounts Payable 3.4m
Accrued Liabilities 6.9m
Short-Term Debt 41.4m
Other Current Liabilities 66.6m
Non-Current Liabilities 31m
Other Non-Current Liabilities 31m
Efficiency

Earnings Waterfall
Armata Pharmaceuticals Inc

Revenue
5.5m USD
Operating Expenses
-46.9m USD
Operating Income
-41.5m USD
Other Expenses
114k USD
Net Income
-41.4m USD

Free Cash Flow Analysis
Armata Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ARMP Profitability Score
Profitability Due Diligence

Armata Pharmaceuticals Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
ROE is Increasing
ROIC is Increasing
Exceptional 1-Year Revenue Growth
31/100
Profitability
Score

Armata Pharmaceuticals Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

ARMP Solvency Score
Solvency Due Diligence

Armata Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Long-Term Solvency
Short-Term Solvency
37/100
Solvency
Score

Armata Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARMP Price Targets Summary
Armata Pharmaceuticals Inc

Wall Street analysts forecast ARMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARMP is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

Lowest
Price Target
7.07 USD
282% Upside
Average
Price Target
7.14 USD
285% Upside
Highest
Price Target
7.35 USD
297% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ARMP?

Click here to dive deeper.

Dividends

Armata Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ARMP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ARMP Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one ARMP stock?

The intrinsic value of one ARMP stock under the Base Case scenario is 2.1836 USD.

Is ARMP stock undervalued or overvalued?

Compared to the current market price of 1.8529 USD, Armata Pharmaceuticals Inc is Undervalued by 15%.

Back to Top